TABLE 1.

Infant Characteristics in Fluticasone and Placebo Groups From Birth to Study Enrollment

CharacteristicPlacebo (N = 16)Fluticasone (N = 16)P Value
Birth weight, g926 ± 251995 ± 439.59
Gestational age, wk27.2 ± 1.727 ± 2.3.26
Male gender, %11 (69)12 (75).69
Multiple gestation, %6 (37.5)4 (25).45
Antenatal glucocorticoid exposure, %12 (75)11 (69).53
Ethnicity, %
    White15 (94)16 (100).31
    Black1 (6)0
Surfactant therapy, %11 (69)14 (88).10
Mechanical ventilation with endotracheal intubation, %11 (69)14 (88).19
Pneumothorax, %01 (6).29
Perivascular interstitial emphysema, %1 (6)2 (13).54
Persistent fetal circulation, %02 (13).14
Persistent ductus arteriosus, %11 (69)6 (38).08
Necrotizing enterocolitis, %1 (6)1 (12).37
Intraventricular hemorrhage, %1 (6)5 (31).07
Periventricular leukomalacia, %2 (13)1 (6).54
Retinopathy, %5 (31)7 (44).47
Hypotension, %1 (6)2 (13).37
Sepsis, %2 (13)2 (13)1.0